FOLH1 and posterior cortical atrophy: Among the above-mentioned [99mTc]Tc-tagged peptides as PSMA inhibitors for PCa SPECT imaging, five have entered clinical trials, where safety and tolerability were evaluated, as well as the determination of key variables such as sensitivity and specificity.